MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia

Muzammil H. Syed(St. Michael's Hospital), Mohammad Qadura(University of Toronto), Hamzah Khan(St. Michael's Hospital), Rawand Abdin(McMaster University), Abdelrahman Zamzam(St. Michael's Hospital), Krishna K. Singh(Western University), Jason Valencia(St. Michael's Hospital), Shubha Jain(St. Michael's Hospital)

Diagnostics

April 17, 2020

10.3390/diagnostics10040230

Cited by 20

Related Papers

Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies

|Stem Cells|2017|205

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response

|Blood|2008|82

BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis

|Journal of Thoracic and Cardiovascular Surgery|2013|69

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice

|Blood|2009|63

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease

|Journal of Clinical Medicine|2020|62